BioNTech COVID-19 vaccine (distribution in China)
GPTKB entity
Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
COVID-19 vaccine distribution
|
| gptkbp:boosters |
Yes
|
| gptkbp:brand |
gptkb:Comirnaty
|
| gptkbp:country |
gptkb:China
|
| gptkbp:distributionStatus |
Available in Hong Kong, Macau, Taiwan
Not available in mainland China (as of 2023) |
| gptkbp:distributor |
gptkb:Fosun_Pharma
|
| gptkbp:firstShipmentDate |
March 2021 (Hong Kong)
March 2021 (Macau) |
| gptkbp:form |
2 doses, 21 days apart
|
| https://www.w3.org/2000/01/rdf-schema#label |
BioNTech COVID-19 vaccine (distribution in China)
|
| gptkbp:manufacturer |
gptkb:Pfizer
gptkb:BioNTech |
| gptkbp:status |
Approved for use in Hong Kong
Approved for use in Macau Approved for use in Taiwan Not approved for general use (as of 2023) |
| gptkbp:storage |
Ultra-cold storage (-70°C)
|
| gptkbp:target |
gptkb:COVID-19
|
| gptkbp:vaccineType |
gptkb:BNT162b2
vaccine |
| gptkbp:bfsParent |
gptkb:Shanghai_Fosun_Pharmaceutical
|
| gptkbp:bfsLayer |
7
|